期刊
JOURNAL OF CLINICAL MEDICINE
卷 9, 期 10, 页码 -出版社
MDPI
DOI: 10.3390/jcm9103267
关键词
TNF-α TNFR1; TNFR2; heart; cardiovascular disease; inflammation; cardiac fibrosis
资金
- Information National Science Centre (Poland) [2016/21/B/NZ5/01397]
Heart disease is a leading cause of death with unmet clinical needs for targeted treatment options. Tumor necrosis factor alpha (TNF-alpha) represents a master pro-inflammatory cytokine that plays an important role in many immunopathogenic processes. Anti-TNF-alpha therapy is widely used in treating autoimmune inflammatory disorders, but in case of patients with heart disease, this treatment was unsuccessful or even harmful. The underlying reasons remain elusive until today. This review summarizes the effects of anti-TNF-alpha treatment in patients with and without heart disease and describes the involvement of TNF-alpha signaling in a number of animal models of cardiovascular diseases. We specifically focused on the role of TNF-alpha in specific cardiovascular conditions and in defined cardiac cell types. Although some mechanisms, mainly in disease development, are quite well known, a comprehensive understanding of TNF-alpha signaling in the failing heart is still incomplete. Published data identify pathogenic and cardioprotective mechanisms of TNF-alpha in the affected heart and highlight the differential role of two TNF-alpha receptors pointing to the complexity of the TNF-alpha signaling. In the light of these findings, it seems that targeting the TNF-alpha pathway in heart disease may show therapeutic benefits, but this approach must be more specific and selectively block pathogenic mechanisms. To this aim, more research is needed to better understand the molecular mechanisms of TNF-alpha signaling in the failing heart.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据